CINXE.COM

<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml"> <head>  <script async src="https://www.googletagmanager.com/gtag/js?id=UA-5483862-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-5483862-1'); </script>  <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-NFW5DS9');</script>  <script> //------------------------------------------------------- var z_account = "2632C1D8-6432-4D3A-93D6-08AAECC53F86"; var z_collector = "asgct.informz.net"; var z_cookieDomain = ".asgct.org"; //------------------------------------------------------- (function (e, o, n, r, t, a, s) { e[t] || (e.GlobalSnowplowNamespace = e.GlobalSnowplowNamespace || [], e.GlobalSnowplowNamespace.push(t), e[t] = function () { (e[t].q = e[t].q || []).push(arguments) }, e[t].q = e[t].q || [], a = o.createElement(n), s = o.getElementsByTagName(n)[0], a.async = 1, a.src = r, s.parentNode.insertBefore(a, s)) }(window, document, "script", "https://"+z_collector+"/web_trk/sp.js", "informz_trk")), informz_trk("newTracker", "infz", z_collector + "/web_trk/collector/", { appId: z_account, cookieDomain: z_cookieDomain }), informz_trk("setUserIdFromLocation", "_zs"), informz_trk("enableActivityTracking", 30, 15); informz_trk("trackPageView", null); </script> <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width,user-scalable=no,maximum-scale=1.0,initial-scale=1.0"> <link href="/BlueKey/assets/css/app.css" rel="stylesheet"> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:description" content="" /> <meta name="twitter:title" content="Video Library | Patients and Clinicians | ASGCT - American Society of Gene & Cell Therapy" /> <meta name="twitter:site" content="https://twitter.com/ASGCTherapy" /> <meta name="twitter:image" content="https://www.asgct.org/getattachment/bb92b3fb-bbd7-4c5c-a0e2-f61bd5b1aedd/attachment.aspx" /> <meta name="twitter:creator" content="@ASGCTherapy" /> <script type="text/javascript" src="//platform-api.sharethis.com/js/sharethis.js#property=5ae883c34d3f70001197fe0b&product=inline-share-buttons"></script>  <script> (function (h, o, t, j, a, r) { h.hj = h.hj || function () { (h.hj.q = h.hj.q || []).push(arguments) }; h._hjSettings = { hjid: 1655159, hjsv: 6 }; a = o.getElementsByTagName('head')[0]; r = o.createElement('script'); r.async = 1; r.src = t + h._hjSettings.hjid + j + h._hjSettings.hjsv; a.appendChild(r); })(window, document, 'https://static.hotjar.com/c/hotjar-', '.js?sv='); </script> <script type="text/javascript"> adroll_adv_id = "LMOGHWAXC5CQHBCHNDJOMB"; adroll_pix_id = "PLJOCPLDXJHPLKUBZAWMIO"; adroll_version = "2.0"; (function(w, d, e, o, a) { w.__adroll_loaded = true; w.adroll = w.adroll || []; w.adroll.f = [ 'setProperties', 'identify', 'track' ]; var roundtripUrl = "https://s.adroll.com/j/" + adroll_adv_id + "/roundtrip.js"; for (a = 0; a < w.adroll.f.length; a++) { w.adroll[w.adroll.f[a]] = w.adroll[w.adroll.f[a]] || (function(n) { return function() { w.adroll.push([ n, arguments ]) } })(w.adroll.f[a]) } e = d.createElement('script'); o = d.getElementsByTagName('script')[0]; e.async = 1; e.src = roundtripUrl; o.parentNode.insertBefore(e, o); })(window, document); adroll.track("pageView"); </script> <script type="text/javascript" defer="defer" src="https://extend.vimeocdn.com/ga/127349852.js"></script><meta charset="UTF-8" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="shortcut icon"/> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="icon"/> <title> Video Library | Patients and Clinicians | ASGCT - American Society of Gene & Cell Therapy | ASGCT - American Society of Gene & Cell Therapy </title></head> <body class="LTR IE IE7 ENUS ContentBody ASGCTRoutingPage"  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NFW5DS9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  <form method="post" action="/video-library/patients-and-clinicians" id="aspnetForm"> <div class="aspNetHidden"> <input type="hidden" name="__CMSCsrfToken" id="__CMSCsrfToken" value="ikqDRMEVQPNABwjOnJqIgTWfBJvwr9cvxBX0Slet13Xuhu49Ulf2LUbZZ+QCTIiG9tLFJaeEN9k0HVSN0SviYAzzxII=" /> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['aspnetForm']; if (!theForm) { theForm = document.aspnetForm; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=UZQNzmZXG1IdUaHxtavOjRvGEvOmz1kvw97PqEaxzBy7Ys-tUotw-RqgdbsvC3g_7cXjehqAdA_N6kbuK73WBAVGdxo1&t=638562384440000000" type="text/javascript"></script> <input type="hidden" name="lng" id="lng" value="en-US" /> <script type="text/javascript"> //<![CDATA[ function PM_Postback(param) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); } if(window.CMSContentManager) { CMSContentManager.allowSubmit = true; }; __doPostBack('ctl00$CMSPortalManager1$am',param); } function PM_Callback(param, callback, ctx) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); }if (window.CMSContentManager) { CMSContentManager.storeContentChangedStatus(); };WebForm_DoCallback('ctl00$CMSPortalManager1$am',param,callback,ctx,null,true); } //]]> </script> <script src="/ScriptResource.axd?d=WTJtoz6EJe-loUBJ9stbRxqzgpVp8oo0KdZGkhGfcu6Lr7kb5LeNfx21FKi8mxEL1oDZOLAxiAqERpClgBx-A6lZ0DJ1qKcDZB1NuIbRd8o9S7aG0&t=7c776dc1" type="text/javascript"></script> <script src="/ScriptResource.axd?d=y6KGkkRaceYF_mkApXCXMQ_rMQVX59BlJ-ut-lQDHw88bR5bbS86epdVNwimj01duE6_OophLX4sBTOgb8_5dNLaY2Mx5DHMJj7Rbr4kPMV1-AOS5VF5-QEC8oG-_-aHoWoyqA2&t=7c776dc1" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var CMS = CMS || {}; CMS.Application = { "isDialog": false, "isDebuggingEnabled": false, "applicationUrl": "/", "isRTL": "false", "imagesUrl": "/CMSPages/GetResource.ashx?image=%5bImages.zip%5d%2f" }; //]]> </script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="C0636174" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAAQBQc8xim6AaS2nANpmJ6r9Wc/UGC0MiqcU6HCwvNVJvgzDekAIswc+CqD21He/aAGQ9TUHX5f3Frmq+VYe3Rj02OzgkMnAwqyZvQAe6Q6LWNn5Xsw=" /> </div> <script type="text/javascript"> //<![CDATA[ Sys.WebForms.PageRequestManager._initialize('ctl00$manScript', 'aspnetForm', ['tctl00$ctxM',''], [], [], 90, 'ctl00'); //]]> </script> <div id="ctl00_ctxM"> </div> <div class="wide"> <header> <div class="container"> <div class="logo"><a href="/"><img src="/BlueKey/assets/images/logo.png" alt="American Society of Gene and Cell Therapy"></a></div> <div class="topSearchWrapper"> <div class="topSearch"> <input type="text" placeholder="Enter Search Text Here"> <input type="submit" value="Go"> </div> <div class="topSearchToggle"></div> </div> <div class="topLinks"> <ul> <li><a href="/contact">Contact Us</a></li> </ul> </div> <div class="socialLinks topSocial"> <ul> <li><a href="https://twitter.com/ASGCTherapy" target="_blank"><i class="bk-icon-twitter"></i></a></li> <li><a href="https://www.facebook.com/asgctherapy" target="_blank"><i class="bk-icon-facebook"></i></a></li> <li><a href="https://www.instagram.com/asgctherapy" target="_blank"><i class="bk-icon-instagram"></i></a></li> <li><a href="https://www.youtube.com/user/ASGCT" target="_blank"><i class="bk-icon-youtube"></i></a></li> <li><a href="https://www.linkedin.com/company/asgct/" target="_blank"><i class="bk-icon-linkedin"></i></a></li> </ul> </div> <div class="topActions"> <input type="submit" name="ctl00$bkSiteHeader$logoutButton$btnSignOut" value="Member Login" id="ctl00_bkSiteHeader_logoutButton_btnSignOut" class="signoutButton btn btn-accent3 ghost btn-default" /> </div> <div class="menuToggle"></div> </div> <div id="ctl00_bkSiteHeader_headerBanner"> <div class="header-alert"> <div class="container"> <p><b><a href="https://annualmeeting.asgct.org/abstracts">Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!</a></b></p> </div> </div> </div> <div class="navShade"></div> <div class="mainNav"> <div class="container"> <ul id="cmsMainNav" class="CMSListMenuUL"> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/annual-meeting">Annual Meeting</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/registration">Register</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/sponsor-exhibit">Sponsor & Exhibit</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/future-annual-meetings">Future Annual Meetings</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/annual-meeting-archives">Annual Meeting Archives</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/program">Program</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/program/workshops">Workshops</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/program/schedule-at-a-glance">Venue Maps</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/abstracts">Abstracts</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/present">Present</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/awards">Awards</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/topics">Topics</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/membership">Membership</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/video-library">Video Library</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/annual-meeting">Annual Meeting</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/cancer">Cancer</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/career-skills">Career Skills</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/gene-editing">Gene Editing</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/patients-and-clinicians">Patients and Clinicians</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/regulatory">Regulatory</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/aav">Viral Vectors</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/become-a-member">Become a Member</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/economy-based-rates">Economy-Based Rates</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/grants-awards">Awards</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/membership-directory-new">Membership Directory</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/scientific-committees">Scientific Committees</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/standing-committees">Standing Committees</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/my-profile">My Profile</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href=" http://jobs.asgct.org/" target="_blank">Career Center</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/submit-an-abstract">ASGCT Abstracts</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/submit-an-abstract/asgct-abstract-submission-windows">Abstract Submission Windows</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/volunteer">Volunteer</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/events">Events</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/2024-advancing-gene-and-cell-therapies-for-cancer">Advancing Gene and Cell Therapies for Cancer</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/2024-advancing-gene-and-cell-therapies-for-cancer/registration">Registration</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/2024-advancing-gene-and-cell-therapies-for-cancer/program">Program</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/2024-advancing-gene-and-cell-therapies-for-cancer/abstracts">Abstracts</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/2024-advancing-gene-and-cell-therapies-for-cancer/speaker-and-attendee-resources-(1)">Speaker + Attendee Resources</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/empowering-patients-2025-a-cell-and-gene-therapies">Empowering Patients 2025: A Cell and Gene Therapies Summit</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/around-the-world-advanced-therapy-medicinal-produc">Around the World: Advanced Therapy Medicinal Production in South America</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/class-considerations-on-immunogenicity-for-aav-gen">Class Considerations on Immunogenicity for AAV GT Products: Assessing Current Practice + New Data</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/molecular-therapy-presents-extracellular-vesicles">Molecular Therapy Presents: Extracellular Vesicles</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/career-development-seminars">Professional Development Caf茅s</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/career-development-seminars/focused-ultrasound-cutting-edge-applications-in-ce">Dec. 13: Focused Ultrasound: Cutting-Edge Applications in Cell and Gene Therapies</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/non-asgct-events">Non-ASGCT Events</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/breakthroughs-in-muscular-dystrophy">Breakthroughs in Muscular Dystrophy</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/registration">Registration</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/abstracts">Abstracts</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/program">Program</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/speaker-and-attendee-resources">Speaker + Attendee Resources</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/sponsorship">Sponsorship</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/awards">Awards</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/honorific-awards">Honorific Awards</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/outstanding-achievement-award">Outstanding Achievement Award</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/outstanding-new-investigator-awards">Outstanding New Investigator Awards</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/george-stamatoyannopoulos-mentorship-award">George Stamatoyannopoulos Mentorship Award</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/excellence-advancing-diversity-equity-inclusion">Award for Excellence in Advancing Diversity, Equity, and Inclusion</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/exemplary-service-award">Exemplary Service Award</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/career-development-awards">Career Development Awards</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/congressional-policy-fellowship">Congressional Policy Fellowship</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/underrepresented-populations-fellowship">Underrepresented Populations in Gene and Cell Therapy</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/mavis-agbandje-mckenna-scholarship-and-fund">Mavis Agbandje-McKenna Scholarship and Fund</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/education">Outreach</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/clinicaltrials">Clinical Trials Finder</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/lunch-learn-events">Community Quick Takes</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/informed-consent">Informed Consent</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/state-of-the-field-highlights-approvals-for-cgt">State of the Field Highlights + Approvals for CGT in 2023</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/access-to-approved-cell-and-gene-therapies">Access to Approved Cell and Gene Therapies</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/genetic-testing-and-clinical-trial-eligibility">Genetic Testing and Clinical Trial Eligibility</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/diversity-equity-and-inclusion-mission-goals">Diversity, Equity, and Inclusion</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/diversity-equity-and-inclusion-mission-goals/biotech-discovery-labs-program">Biotech Discovery Labs Program</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/gene-therapy-101">Patient Education: Gene Therapy 101</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-therapy-basics">Gene Therapy Basics</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-therapy-approaches">Gene Therapy Approaches</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/developing-a-treatment">Clinical Trials Process</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/vectors-101">Vectors 101</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-editing">Gene Editing</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/global-outreach">Global Outreach</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/disease-treatments">Patient Education: Condition Treatments</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/beta-thalassemia-other-blood-disorders">Beta Thalassemia & Other Blood Disorders</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/leukodystrophy">CALD and MLD</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/spinal-muscular-atrophy">Spinal Muscular Atrophy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/blood-cancers-car-t-cell-therapy">CAR-T Basics</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/hemophilia-gene-therapy">Hemophilia</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/publications">Publications</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/news">ASGCT Blog</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-patient-press">The Patient Press</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/the-patient-press/october-2024">October 2024</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-vector">The Vector</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/landscape-report">Quarterly Gene, Cell, and RNA Therapy Landscape Report</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/asgct-podcast-network">ASGCT Podcast Network</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/giants-of-gene-therapy">Giants of Gene Therapy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/the-issue">The Issue</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/the-molecular-therapy-podcast">The Molecular Therapy Podcast</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-advocate">The Advocate</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/the-advocate/subscribe-to-the-advocate">Subscribe to The Advocate</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/molecular-therapy">Molecular Therapy Family</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/molecular-therapy-presents-targets-and-biomarkers">Molecular Therapy Presents Extracellular Vesicles</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/cell-press-webinar-advances-in-viral-vector-gene-d">Cell Press Webinar: Advances in Viral Vector Gene Delivery for CT Biomanufacturing</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/molecular-therapy">Molecular Therapy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt鈥搈ethods-clinical-development">MT Methods & Clinical Development</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt鈥搉ucleic-acids">MT Nucleic Acids</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt鈥搊ncolytics">MT Oncology</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/advocacy">Advocacy</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/events-and-opportunities">Events and Opportunities</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/policy-summit">Policy Summit</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/asgct-fda-liaison-meeting-(1)">ASGCT-FDA Liaison Meeting</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/cgt-science-series">Cell + Gene Therapy Science Series</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/congressional-policy-fellowship">Congressional Policy Fellowship</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/fda-immune-responses-aav-vectors">FDA & ASGCT: Immune Responses to AAV Vectors</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/policy-priorities">Policy Priorities</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/patient-access-overview">Patient Access Overview</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/regulatory-policy">Regulatory Policy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/research-funding">Research Funding</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/the-advocate">The Advocate</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/the-advocate/subscribe-to-the-advocate">Subscribe to The Advocate</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/policy-statements-letters">Policy Statements & Letters</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/about">About</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/leadership">Leadership</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/board-officers">Board of Directors</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/scientific-committees">Scientific Committees</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/standing-committees">Standing Committees</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/staff">Staff</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/careers">Work at ASGCT</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/development-coordinator">Development Coordinator</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/education-coordinator">Education Coordinator</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/meeting-planner">Meeting Planner</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/media">Media</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/culture">Our Culture</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/strategic-plan">Strategic Plan</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/meeting-code-of-conduct">Meeting Code of Conduct</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/terms-and-conditions">Terms and Conditions</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/mission-vision">Mission & Vision</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/mission-vision/bylaws">Bylaws</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/support">Support ASGCT</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/annual-meeting-support">Annual Meeting Support</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/advertise-asgct-publications">Advertise in ASGCT Publications</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/support-asgct-s-digital-programs">Digital Programs</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/giving">Giving</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/year-round-support">Year-Round Support</a></li></ul></li></ul> </div> </li> </ul> </div> <div class="mainNavClose"></div> </div> </header> <div class="masthead" style="background: url('/getattachment/Video-Library/Patients-and-Clinicians/banner-patients-clinicians-(1).png.aspx') 50% 50% no-repeat; background-size: cover;"> <div class="container"></div> </div> <section class="routingIntro"> <div class="container"> <h1>Patients and Clinicians</h1> <p>Browse and view ASGCT's patient and clinician-focused content on-demand. This resource is made available exclusively for ASGCT members.</p> </div> </section> <section class="contentFeatureSection"> <div class="container"> <div class="meetingBoxContainer"> <div class="meetingFeature"> <div class="meetingFeatureContent"> <h2><a href="/membership/become-a-member">Not an ASGCT Member? Join Today!</a></h2> <p>ASGCT membership unlocks incredible discounts and on-demand access to a rich archive documenting the history of cell and gene therapy. Take the next step in your career by becoming an ASGCT member.</p> <div class="meetingFeatureAction"> <p><a class="btn btn-accent3" href="/membership/become-a-member">Join</a></p> </div> </div> </div> </div> </div> </section> <section class="routingBlockSection"> <div class="container"> <h2>Find Patient and Clinician Content</h2> <div class="card-deck"> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/advancing-clinical-research-of-gene-therapies-in-b">Advancing Clinical Research of Gene Therapies in Brazil</a></h4> <p class="card-text"><strong>December 2, 2020</strong><br /> This event is in partnership between ASGCT and the Brazilian Association of Cellular and Gene Therapy. The goal of this program is for speakers with experience in clinical development to share their experiences and insights on factors to consider to successfully initiate clinical trials of <em>in vivo</em> and <em>ex vivo</em> gene therapies in Brazil. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/advancing-clinical-research-of-gene-therapies-in-b">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/advancing-cell-and-gene-therapy-in-china">Around the World: Advancing Cell and Gene Therapy in China</a></h4> <p class="card-text"><strong>April 18, 2023</strong><br /> Speakers from China share their expertise in development of vaccines and gene therapies. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/advancing-cell-and-gene-therapy-in-china">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/around-the-world-gene-therapy-for-the-liver-eye-he">Around the World: Gene Therapy for the Liver Eye Hematopoietic System in Australia</a></h4> <p class="card-text"><strong>August 30, 2023</strong><br /> Learn from Australian researchers working on gene therapy for the liver, eye, and haematopoietic system. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/around-the-world-gene-therapy-for-the-liver-eye-he">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/around-the-world-innovation-in-japan">Around the World: Innovation in Japan</a></h4> <p class="card-text"><strong>March 27, 2024</strong><br /> Discover the latest breakthroughs in gene and cell therapy research through an exclusive webinar collaboration between the American Society of Gene and Cell Therapy and the Japanese Society of Gene and Cell Therapy, fostering international collaboration and knowledge exchange. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/around-the-world-innovation-in-japan">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/nord-webinars">ASGCT-NORD Webinars</a></h4> <p class="card-text"><strong>September 19, 2019</strong><br /> During each of these five webinars, hear from clinicians, patients, and others at various stages of receiving gene therapy treatments. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/nord-webinars">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/best-of-annual-meeting-abstracts">Best of Annual Meeting Abstracts</a></h4> <p class="card-text"><strong>October 16, 2023</strong><br /> Dive deep into the latest research and discoveries from past Annual Meeting abstracts. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/best-of-annual-meeting-abstracts">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/cell-therapies-in-the-middle-east">Cell Therapies in the Middle East: Where Do We Stand?</a></h4> <p class="card-text"><strong>June 15-16, 2022</strong><br /> During this free two-day symposium, speakers from around the world shared their insights and experience in development of cell therapies in the Middle East. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/cell-therapies-in-the-middle-east">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/clinical-aspects-immune-responses-long-covid-patie">Clinical Aspects and Immune Responses in Long COVID Patients</a></h4> <p class="card-text"><strong>January 25, 2022</strong><br /> Speakers give a general overview of the pathogenesis of COVID-19, describe clinical aspects of long COVID, address aberrant immune responses in patients with long COVID, and discuss how neurological damage caused by the virus may contribute to persisting symptoms. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/clinical-aspects-immune-responses-long-covid-patie">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/clinical-gene-therapy-indo-uk-symposium">Clinical Gene Therapy: Indo-UK Symposium</a></h4> <p class="card-text"><strong>October 9, 2021</strong><br /> During this free virtual symposium, attendees gain insights on how to successfully initiate trials of in vivo and ex vivo gene therapies in India. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/clinical-gene-therapy-indo-uk-symposium">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/access-to-approved-cell-and-gene-therapies-communi">Community Quick Takes: Access to Approved Cell and Gene Therapies</a></h4> <p class="card-text"><strong>June 5, 2024</strong><br /> Patients accessing cell and gene therapies (CGTs) can face barriers in development, eligibility, coverage, referrals, and logistics. ASGCT experts discuss approved products, eligibility criteria, CAR-T lessons, provider knowledge, and how CGTs excite families compared to current sickle cell care. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/access-to-approved-cell-and-gene-therapies-communi">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/community-quick-takes-informed-consent">Community Quick Takes: Informed Consent</a></h4> <p class="card-text"><strong>December 5, 2023</strong><br /> Listen to Quick Takes from experts Samuel Hughes, MBA; Jean Johnston, and Jodi Wolff, PhD. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/community-quick-takes-informed-consent">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/delivery-to-skeletal-muscles-breaking-barriers-gen">Delivery to Skeletal Muscles: Breaking Barriers for Genetic Medicine</a></h4> <p class="card-text"><strong>October 19, 2022</strong><br /> In this session we explore use of gene therapy approaches to treat Pompe disease and discuss challenges as well as novel uses of AAV to treat neuromuscular disorders. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/delivery-to-skeletal-muscles-breaking-barriers-gen">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/forum-on-gene-therapy-for-underserved-populations">Forum on Gene Therapy for Underserved Populations</a></h4> <p class="card-text"><strong>June 22, 2021</strong><br /> Key stakeholders in the space will present a variety of novel models for the development of gene therapy for people with ultra-rare diseases and those living in countries with lower income economies. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/forum-on-gene-therapy-for-underserved-populations">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/mmune-responses-to-gene-therapies-for-musculoskele">Immune Responses to Gene Therapies for Musculoskeletal and Cardiac Diseases</a></h4> <p class="card-text"><strong>February 23, 2022</strong><br /> This session highlights the ongoing research related to the administration of high-dose adeno-associated virus (AAV) in patients with an emphasis on safety and tolerability findings. Speakers provide a better understanding of the responses of patients to systemic delivery of AAV and the array of related factors. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/mmune-responses-to-gene-therapies-for-musculoskele">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/latest-research-and-ethical-considerations-for-tar">Latest Research and Ethical Considerations for Targeted Insertion of Genes into the Human Genome</a></h4> <p class="card-text"><strong>December 7, 2022</strong><br /> After decades of research, gene editing has made its way into the clinic - but technical and ethical challenges remain. Speakers during this session give attendees an overview of the development history of gene editing technologies and present some of the newest research in the field. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/latest-research-and-ethical-considerations-for-tar">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-annual-meeting-research-highlights">Lunch and Learn: Annual Meeting Research Highlights</a></h4> <p class="card-text"><strong>June 23, 2022</strong><br /> Members of the Patient Outreach Committee who were onsite at the meeting attended oral abstract sessions and prepared to report on any new and relevant findings. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-annual-meeting-research-highlights">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-diving-into-preclinical-studies">Lunch and Learn: Diving into Preclinical Studies</a></h4> <p class="card-text"><strong>July 28, 2022</strong><br /> Researchers break down the preclinical models for gene therapies and a patient advocate shares direct examples of how communities can gather this data to further expand the knowledge around their disease and possible treatments. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-diving-into-preclinical-studies">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-gene-therapy-101">Lunch and Learn: Gene Therapy 101</a></h4> <p class="card-text"><strong>February 24, 2022</strong><br /> Experts in the field review different gene therapy approaches, disease applications, and research processes, and describe the current state of the field. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-gene-therapy-101">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-gene-therapy-for-sma">Lunch and Learn: Gene Therapy for SMA</a></h4> <p class="card-text"><strong>September 10, 2021</strong><br /> Clinicians share insights on gene therapy options for SMA and a parent discusses having a child receive approved treatments. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-gene-therapy-for-sma">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-intro-to-non-viral-vectors">Lunch and Learn: Intro to Non-Viral Vectors</a></h4> <p class="card-text"><strong>April 27, 2023</strong><br /> There are different kinds of <a href="https://patienteducation.asgct.org/gene-therapy-101/vectors-101">vectors</a>, or delivery methods, used in gene and cell therapy to get working genetic material to a cell. This session explores the use of non-viral vectors as a mechanism to deliver this material and give examples and reason for being used over traditional viral vectors. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-intro-to-non-viral-vectors">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-intro-to-viral-vectors">Lunch and Learn: Intro to Viral Vectors</a></h4> <p class="card-text"><strong>March 31, 2022</strong><br /> During this event, experts in the field dive further into viral vectors, a common delivery approach used in gene therapy. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-intro-to-viral-vectors">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-meet-the-patients">Lunch and Learn: Meet the Patients</a></h4> <p class="card-text"><strong>January 27, 2023</strong><br /> Join us as patients highlight their stories, from navigating the diagnosis process to learning about and receiving investigational treatment options. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-meet-the-patients">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-meet-the-researchers">Lunch and Learn: Meet the Researchers</a></h4> <p class="card-text"><strong>October 27, 2022</strong><br /> Attendees will learn about how researchers work with patient organizations to help advance science around a particular disease or disorder, and how they interact with other stakeholders to further their findings. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-meet-the-researchers">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-navigating-the-patient-provider-co">Lunch and Learn: Navigating the Patient Provider Conversation</a></h4> <p class="card-text"><strong>November 17, 2022</strong><br /> A clinician and caregiver give their perspectives and advice on navigating the diagnosis process to considering a treatment plan related to gene therapy. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-navigating-the-patient-provider-co">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-routes-of-administration">Lunch and Learn: Routes of Administration</a></h4> <p class="card-text"><strong>August 25, 2022</strong><br /> During this Lunch & Learn, we break down the most common routes of gene therapy drug delivery and review the preclinical study model and how these routes are currently used in certain approved therapies or clinical trials. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/lunch-and-learn-routes-of-administration">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/neural-cardiac-cellular-reprogramming">Neural and Cardiac Cellular Reprogramming</a></h4> <p class="card-text"><strong>November 16, 2022</strong><br /> This session explores approaches and tools for achieving cell lineage specification through reprogramming, noting both progress and pitfalls. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/neural-cardiac-cellular-reprogramming">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/science-literacy-educating-others-by-taking-back-t">Science Literacy: Educating Others by Taking Back the Story</a></h4> <p class="card-text"><strong>September 16, 2022</strong><br /> Talking about our profession is not an easy thing to do with people outside of the lab. Join Grant Holley, PhD, for a Professional Development Caf茅 on how to better talk about and educate differing audiences on what you do and why you do it. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/science-literacy-educating-others-by-taking-back-t">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/scientific-horizons-and-ethical-limits-of-gene-and">Scientific Horizons and Ethical Limits of Gene and Cell Therapy</a></h4> <p class="card-text"><strong>November 18, 2022</strong><br /> This session explores foundational cases in biomedical research (e.g., embryo culture, biobanking, translational research, CRISPR) that have shaped approaches to defining ethical limits and the forms of deliberation, participation, exclusion, and oversight they exemplify. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/scientific-horizons-and-ethical-limits-of-gene-and">Watch now</a></div> </div> </div> </div> <div class="card"> <div class="card-block"> <h4 class="card-title"><a href="https://www.asgct.org/video-library/patients-and-clinicians/treating-genetic-diseases-prior-to-birth">Treating Genetic Diseases Prior to Birth</a></h4> <p class="card-text"><strong>October 19, 2023</strong><br /> Explore cutting-edge prenatal cell and gene therapy tools and the ethics involved. 馃敀</p> <div class="meetingFeatureAction"> <div class="card-footer"><a class="more" href="https://www.asgct.org/video-library/patients-and-clinicians/treating-genetic-diseases-prior-to-birth">Watch now</a></div> </div> </div> </div> </div> </div> </section> <div class="event-row"> <div class="year">2024</div> <div class="content"> <h2>Breakthroughs in Muscular Dystrophy</h2> <p>November 19-20, 2024 | Chicago, IL</p> </div> <div class="action"><a class="btn btn-white" href="/events/breakthroughs-in-muscular-dystrophy">Learn More</a></div> </div> <footer> <div class="container"> <div class="footerColContainer"> <div class="footerCol"> <p><img alt="logo-footer.png" class="footerLogo" src="/getmedia/c77b7df1-12a2-4998-9809-0a880c107341/ASGCT_Web_Horz_White.aspx" title="logo-footer.png" /></p> <p>20800 Swenson Dr.<br /> Suite 300<br /> Waukesha, WI 53186</p> </div> <div class="footerCol"> <ul> <li><a href="/about">About</a></li> <li><a href="/membership">Membership</a></li> <li><a href="https://annualmeeting.asgct.org" target="_blank">Annual Meeting</a></li> <li><a href="http://www.cell.com/molecular-therapy-family/home" target="_blank">Journal</a></li> </ul> </div> <div class="footerCol"> <ul> <li><a href="/education">Education</a></li> <li><a href="/advocacy">Advocacy</a></li> <li><a href="https://asgct.org/awards" target="_blank">Awards</a></li> <li><a href="https://asgct.org/about/privacy-policy" target="_blank">Privacy Policy</a></li> </ul> </div> <div class="footerCol"> <p class="altStyle">Connect with ASGCT</p> <p><strong>Phone:</strong> 414.278.1341<br /> <a href="mailto:info@asgct.org">info@asgct.org</a><div class="footerSocial"><div id="ctl00_bkSiteFooter_rptFooterBlocks_ctl04_widget1_ctl00_divSocialLinks" class="socialLinks footerSocial"> <ul> <li><a href="https://twitter.com/ASGCTherapy" target="_blank"><i class="bk-icon-twitter"></i></a></li> <li><a href="https://www.facebook.com/asgctherapy" target="_blank"><i class="bk-icon-facebook"></i></a></li> <li><a href="https://www.instagram.com/asgctherapy" target="_blank"><i class="bk-icon-instagram"></i></a></li> <li><a href="https://www.youtube.com/user/ASGCT" target="_blank"><i class="bk-icon-youtube"></i></a></li> <li><a href="https://www.linkedin.com/company/asgct/" target="_blank"><i class="bk-icon-linkedin"></i></a></li> </ul> </div></div></p> </div> </div> </div> </footer> <div class="postFooter"> <div class="container"> <p>© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy. </p> <p class="bkCredit"><a href="https://www.reasononeinc.com/kentico" title="BlueKey is a Full Service Digital Agency and Kentico Gold Partner. Click to learn more about our Kentico development services" target="_blank">Kentico CMS Development by Reason One</a> | <a href="http://www.kentico.com" target="_blank">Powered by Kentico</a></p> </div> </div> <div class="CookieConsent"> <span id="ctl00_cookieLawQ_lblText" class="ConsentText">This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.</span> <span class="ConsentButtons"> <input type="submit" name="ctl00$cookieLawQ$btnAllowSpecific" value="OPT OUT" id="ctl00_cookieLawQ_btnAllowSpecific" class="ConsentButton btn btn-default" /> <input type="submit" name="ctl00$cookieLawQ$btnAllowAll" value="ACCEPT" id="ctl00_cookieLawQ_btnAllowAll" class="ConsentButton btn btn-default" /> </span> </div> <script src="/BlueKey/assets/js/app-dist.js"></script> <script src="/BlueKey/assets/js/timeline-dist.js"></script> </div> <script type="text/javascript"> //<![CDATA[ var callBackFrameUrl='/WebResource.axd?d=nNME_ObE2oIDm535eYM9xWmIMy-HXBVdo54Ly6sA5tAYPS1aA-gFDzodlP9ijTBRgmjStONrH4-ISuRTp7slHiYkACw1&t=638562384440000000'; WebForm_InitCallback();//]]> </script> </form> </body> </html>